CAPR Class Alert: Capricor Therapeutics Securities Fraud Class Action to Recover Losses is Pending – Investors Notified to Contact BFA Law before September 28 Court Deadline

A securities-fraud class action seeking to recover investor losses is pending against Capricor Therapeutics, with investors instructed to contact BFA Law before the September 28 lead-plaintiff deadline. The notice signals material litigation risk for the biotech company, though no alleged damages, financial impact, or case-specific allegations were provided.